2023 WHO 技术文件:疟疾化学预防

2023-04-20 世界卫生组织 WHO官网 发表于香港

本文件介绍了用于开发儿童、孕妇和非免疫旅行者疟疾化学预防药物的 PPC。

中文标题:

2023 WHO 技术文件:疟疾化学预防

英文标题:

Malaria chemoprevention

发布机构:

世界卫生组织

发布日期:

2023-04-20

简要介绍:

首选产品特性”(PPC) 是激励和引导开发急需保健产品的关键工具。此处发布的 PPC 旨在阐明疟疾化学预防药物的公共卫生需求、首选特征和临床开发注意事项。世卫组织推荐了几种控制疟疾的化学预防策略,包括季节性疟疾化学预防、常年疟疾化学预防、妊娠期疟疾间歇性预防治疗和大规模药物管理。这些策略面临许多挑战,例如依从性和覆盖率不理想以及耐药性的出现和传播。本文件介绍了用于开发儿童、孕妇和非免疫旅行者疟疾化学预防药物的 PPC。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2023 WHO 技术文件:疟疾化学预防.pdf)] GetToolGuiderByIdResponse(projectId=1, id=4d66b1c00310a26d, title=2023 WHO 技术文件:疟疾化学预防, enTitle=Malaria chemoprevention, guiderFrom=WHO官网, authorId=0, author=, summary=本文件介绍了用于开发儿童、孕妇和非免疫旅行者疟疾化学预防药物的 PPC。, cover=https://img.medsci.cn/Random/doctor-is-working-at-the-hospital-PAJM2K5.jpg, journalId=0, articlesId=null, associationId=138, associationName=世界卫生组织, associationIntro=null, copyright=0, guiderPublishedTime=Thu Apr 20 00:00:00 CST 2023, originalUrl=, linkOutUrl=, content=<p>首选产品特性&rdquo;(PPC) 是激励和引导开发急需保健产品的关键工具。此处发布的 PPC 旨在阐明疟疾化学预防药物的公共卫生需求、首选特征和临床开发注意事项。世卫组织推荐了几种控制疟疾的化学预防策略,包括季节性疟疾化学预防、常年疟疾化学预防、妊娠期疟疾间歇性预防治疗和大规模药物管理。这些策略面临许多挑战,例如依从性和覆盖率不理想以及耐药性的出现和传播。本文件介绍了用于开发儿童、孕妇和非免疫旅行者疟疾化学预防药物的 PPC。</p>, tagList=[TagDto(tagId=474544, tagName=疟疾化学预防)], categoryList=[CategoryDto(categoryId=9, categoryName=传染科, tenant=100), CategoryDto(categoryId=35, categoryName=预防公卫, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=5313, articleKeyword=疟疾, articleKeywordNum=6, guiderKeywordId=5313, guiderKeyword=疟疾, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=文档, guiderLanguage=1, guiderRegion=10, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=24943, appHits=162, showAppHits=0, pcHits=110, showPcHits=24780, likes=0, shares=133, comments=4, approvalStatus=1, publishedTime=Tue Apr 25 20:34:00 CST 2023, publishedTimeString=2023-04-20, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=dajiong, createdTime=Fri Apr 21 10:36:31 CST 2023, updatedBy=4754896, updatedName=侠胆医心, updatedTime=Sun Dec 31 03:46:33 CST 2023, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=香港, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2023 WHO 技术文件:疟疾化学预防.pdf)])
2023 WHO 技术文件:疟疾化学预防.pdf
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2128484, encodeId=12d22128484b8, content=<a href='/topic/show?id=f293e0435d6' target=_blank style='color:#2F92EE;'>#疟疾#</a><a href='/topic/show?id=2dcb33531fd' target=_blank style='color:#2F92EE;'>#化学预防#</a><a href='/topic/show?id=4f811868096' target=_blank style='color:#2F92EE;'>#WHO#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70435, encryptionId=f293e0435d6, topicName=疟疾), TopicDto(id=33531, encryptionId=2dcb33531fd, topicName=化学预防), TopicDto(id=18680, encryptionId=4f811868096, topicName=WHO)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Apr 26 19:37:07 CST 2023, time=2023-04-26, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2128310, encodeId=07b22128310b5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b575324597, createdName=148b6ed5m11暂无昵称, createdTime=Tue Apr 25 21:35:25 CST 2023, time=2023-04-25, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2128303, encodeId=abc9212830375, content=疟疾防控仍然任重道远, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02bf2579143, createdName=1259e64fm26暂无昵称, createdTime=Tue Apr 25 20:55:57 CST 2023, time=2023-04-25, status=1, ipAttribution=辽宁省)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2128484, encodeId=12d22128484b8, content=<a href='/topic/show?id=f293e0435d6' target=_blank style='color:#2F92EE;'>#疟疾#</a><a href='/topic/show?id=2dcb33531fd' target=_blank style='color:#2F92EE;'>#化学预防#</a><a href='/topic/show?id=4f811868096' target=_blank style='color:#2F92EE;'>#WHO#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70435, encryptionId=f293e0435d6, topicName=疟疾), TopicDto(id=33531, encryptionId=2dcb33531fd, topicName=化学预防), TopicDto(id=18680, encryptionId=4f811868096, topicName=WHO)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Apr 26 19:37:07 CST 2023, time=2023-04-26, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2128310, encodeId=07b22128310b5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b575324597, createdName=148b6ed5m11暂无昵称, createdTime=Tue Apr 25 21:35:25 CST 2023, time=2023-04-25, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2128303, encodeId=abc9212830375, content=疟疾防控仍然任重道远, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02bf2579143, createdName=1259e64fm26暂无昵称, createdTime=Tue Apr 25 20:55:57 CST 2023, time=2023-04-25, status=1, ipAttribution=辽宁省)]
    2023-04-25 148b6ed5m11暂无昵称 来自辽宁省

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2128484, encodeId=12d22128484b8, content=<a href='/topic/show?id=f293e0435d6' target=_blank style='color:#2F92EE;'>#疟疾#</a><a href='/topic/show?id=2dcb33531fd' target=_blank style='color:#2F92EE;'>#化学预防#</a><a href='/topic/show?id=4f811868096' target=_blank style='color:#2F92EE;'>#WHO#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70435, encryptionId=f293e0435d6, topicName=疟疾), TopicDto(id=33531, encryptionId=2dcb33531fd, topicName=化学预防), TopicDto(id=18680, encryptionId=4f811868096, topicName=WHO)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Apr 26 19:37:07 CST 2023, time=2023-04-26, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2128310, encodeId=07b22128310b5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b575324597, createdName=148b6ed5m11暂无昵称, createdTime=Tue Apr 25 21:35:25 CST 2023, time=2023-04-25, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2128303, encodeId=abc9212830375, content=疟疾防控仍然任重道远, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02bf2579143, createdName=1259e64fm26暂无昵称, createdTime=Tue Apr 25 20:55:57 CST 2023, time=2023-04-25, status=1, ipAttribution=辽宁省)]
    2023-04-25 1259e64fm26暂无昵称 来自辽宁省

    疟疾防控仍然任重道远

    0

拓展阅读

疟疾,与国家命运相关。

疟疾,一个由蚊虫叮咬感染上的疾病,发病的病人会时而寒战,时而发热,红细胞会破坏,会贫血,脾脏会增大,严重的会致死。

国家卫健委发文,基层医生有新任务

各地要高度重视,严格贯彻落实~

新型灭蚊策略使蚊子永远无法性成熟!让其断子绝孙

蚊子通常传播的疾病包括疟疾、登革热、乙脑、基孔肯雅热,这几种疾病对人体都会产生很大危害

武汉同济医院92岁赵灿熙教授因发现亳菊抗疟疾获国际金奖!

赵灿熙教授在全球首次发现中药芜荑中的成分亳菊具有良好的抗疟作用,鉴于目前恶性疟疾产生了普遍的抗药性,该发现有望成为疟疾治疗的补充。

CMI:COVID-19和疟疾合并感染对临床结局的影响

在疟疾流行地区抗击新冠肺炎病毒受到了生态学研究的影响,这些研究表明,疟疾发病率较高的国家往往具有较低的新冠肺炎死亡率

NEJM:危险!疟疾大本营非洲确认出现抗青蒿素疟疾突变!青蒿素疗法面临失败,5年内可能增加7800万感染者

2021年9月23日,日本顺天堂大学的研究人员在国际顶尖医学期刊《新英格兰医学期刊》(NEJM)发表了题为:Evidence of Artemisinin-Resistant Malaria in A

2022 WHO指南:疟疾

世界卫生组织(WHO,The World Health Organization) · 2022-02-18

2022 BSH指南:疟疾的实验室诊断

英国血液病学学会(BSH,British Society for Haematology) · 2022-03-09

2022 WHO指南:疟疾(6月)

世界卫生组织(WHO,The World Health Organization) · 2022-06-03

疟疾诊疗指南

浙江大学医学院附属第一医院 · 2022-07-29

疟疾诊疗指南(更新版)

国家传染病医学中心撰写组 · 2022-08-23

2022 WHO指南:疟疾(11月更新)

世界卫生组织(WHO,The World Health Organization) · 2022-11-25